Fractionation of charged keratin

Patent metadata

Field	Value
Publication number	US-10195314-B2
Application number	US-201514839060-A
Country	US
Kind code	B2
Filing date	Aug 28, 2015
Priority date	Feb 17, 2006
Publication date	Feb 5, 2019
Grant date	Feb 5, 2019

Abstract

Methods are provided to produce optimal fractionations of charged keratins that have superior biomedical activity. Also provided are medical implants coated with these keratin preparations. Further provided are methods of treating blood coagulation in a patient in need thereof.

First claim

That which is claimed is:

1. A method of producing a charged fraction of keratin, comprising:
providing a solution comprising acidic and basic keratin, wherein said solution has a pH of between 6 and 7, and wherein said solution is provided by:
reacting human hair with thioglycolic acid, and
extracting said acidic and basic keratin with a solution comprising tris base;

separating a fraction of said acidic keratin or a fraction of said basic keratin from said solution comprising said acidic and basic keratin, wherein said separating is carried out by chromatography; and
collecting said fraction;
to produce the charged fraction of keratin.

2. The method of claim 1 , wherein said keratin comprises alpha keratin.

3. The method of claim 1 , wherein said keratin comprises gamma keratin.

4. A method of producing a charged fraction of alpha keratin, comprising:
providing a solution comprising keratin, wherein said solution is provided by:
reacting human hair with thioglycolic acid, and
extracting said keratin with a solution comprising tris base;

precipitating alpha keratin from said solution comprising keratin by addition of mineral acid to a pH of approximately 4;
separating precipitated alpha keratin from said solution comprising keratin;
collecting the precipitated alpha keratin; and then,
optionally, re-dissolving the alpha keratin at pH 9 and re-precipitating at pH 4 to further purify; and then,
re-dissolving the alpha keratin to provide a purified alpha keratin solution and adjusting the pH of the purified alpha keratin solution to be between 6 and 7,wherein the purified alpha keratin solution comprises acidic and basic alpha keratin; and then,
separating a fraction of said acidic alpha keratin or a fraction of said basic alpha keratin from said purified alpha keratin solution, wherein said separating is carried out by chromatography; and
collecting said fraction;
to thereby produce the charged fraction of alpha keratin.

5. The method of claim 1 , wherein said keratin comprises at least 80% by weight of alpha keratin.

6. The method of claim 1 , wherein said keratin comprises at least 90% by weight of alpha keratin.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Van Dyke Mark E

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P9/10

  for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

• A61P7/04

  Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents · CPC title

• A61P7/02

  Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors · CPC title

• A61L31/10

  Macromolecular materials · CPC title